Peer-Reviewed Journal Details
Mandatory Fields
Monnereau A.;Glaser S.;Schupp C.;Smedby K.;De Sanjosé S.;Kane E.;Melbye M.;Forétova L.;Maynadié M.;Staines A.;Becker N.;Nieters A.;Brennan P.;Boffetta P.;Cocco P.;Glimelius I.;Clavel J.;Hjalgrim H.;Chang E.
2013
November
Blood
Exposure to UV radiation and risk of Hodgkin lymphoma: A pooled analysis
Published
19 ()
Optional Fields
122
20
3492
3499
Ultraviolet radiation (UVR) exposure has been inversely associated with Hodgkin lymphoma (HL) risk, but only inconsistently, only in a few studies, and without attention to HL heterogeneity. We conducted a pooled analysis of HL risk focusing on type and timing of UVR exposure and on disease subtypes by age, histology, and tumor-cell Epstein-Barr virus (EBV) status. Four case-control studies contributed 1320HLcasesand 6381 controls. We estimated lifetime, adulthood, and childhood UVR exposure and history of sunburn and sunlamp use. We used 2-stage estimation with mixed-effects models and weighted pooled effect estimates by inverse marginal variances. We observed statistically significant inverse associations with HL risk for UVR exposures during childhood and adulthood, sunburn history, and sunlamp use, but we found no significant doseresponse relationships. Risks were significant only for EBV-positive HL (pooled odds ratio, 0.56; 95% confidence interval, 0.35 to 0.91 for the highest overall UVR exposure category), with a significant linear trend for overall exposure (P 5.03). Pooled relative risk estimates were not heterogeneous across studies. Increased UVR exposure may protect against HL, particularly EBV-positive HL. Plausible mechanisms involving UVR induction of regulatory T cells or the cellular DNA damage response suggest opportunities for new prevention targets. © 2013 by The American Society of Hematology.
0006-4971
10.1182/blood-2013-04-497586
Grant Details